The nurse reviews instructions with a patient who is on insulin injections as part of their therapy.
The nurse asks the patient, "What should you do if your fasting blood glucose is 48 mg/dL?" Which response by the patient reflects a correct understanding of insulin therapy?

This question tests patient understanding of potassium-sparing diuretics. It requires identifying the need for further education when a patient plans to alter their medication dosage independently, which poses a severe risk of life-threatening electrolyte imbalances, particularly hyperkalemia, in patients prescribed this diuretic therapy.

Choice A rationale

Taking spironolactone with food is recommended as it helps to increase the drug's oral bioavailability and significantly reduces the common gastrointestinal side effects, such as nausea or stomach upset, which are frequently reported by patients during the initial weeks of treatment.

Choice B rationale

Patients must never independently alter their medication dose. Spironolactone acts as an aldosterone antagonist, and self-adjusting the dose can lead to erratic blood pressure control or severe, potentially life-threatening hyperkalemia, which is a significant clinical risk requiring ongoing provider monitoring.

Choice C rationale

Spironolactone can cause hyperkalemia, which significantly increases the risk of cardiac dysrhythmias. Patients are rightly taught to monitor for signs of irregular heartbeats, such as palpitations or skipped beats, and report these concerns immediately to ensure proper cardiovascular safety and monitoring.

Choice D rationale

Salt substitutes often contain potassium chloride, and potassium-rich foods can contribute to dangerous elevations in serum potassium levels. Patients on spironolactone are at a high risk for hyperkalemia (normal range 3.5 to 5.0 mEq/L) and must avoid these dietary sources.

This question tests the understanding of pharmacokinetics, specifically the relationship between plasma protein binding and drug distribution. It requires applying knowledge of how decreased albumin levels shift the equilibrium, resulting in a higher free drug fraction available to bind with cellular receptors.

Choice A rationale

Protein binding is a critical pharmacokinetic parameter. Only the unbound or free fraction of a drug can distribute into tissues and interact with receptors to produce a pharmacologic effect; therefore, plasma protein levels significantly influence drug activity levels.

Choice B rationale

Albumin is the primary plasma protein that binds acidic drugs. When albumin levels are low, normal range 3.5 to 5.0 g/dL, the fraction of free, active drug increases. This leads to an intensified pharmacologic effect and an increased risk of toxicity.

Choice C rationale

A medication does not become inactive solely due to low albumin. In reality, the drug remains pharmacologically active because the free fraction is the active component. Low albumin levels increase the available free drug, potentially leading to a dangerous overdose.

Choice D rationale

This is incorrect because the drug does not require albumin for activity; it is the free form that binds receptors. Lower albumin levels actually result in more free drug available in the systemic circulation to bind receptors and exert effects.